CLINICAL_TRIALS trial_result · 2022-10-20

Clinical Trial Update: MAIN STUDY: SWITCH SUB-STUDY: SWITCH-JCV [Phase 4]

Phase 4 clinical trial update for the MAIN STUDY: SWITCH sub-study SWITCH-JCV in multiple sclerosis has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Providence Health & Services | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2022-10-20